.avif)
Ipsen Email Format
Pharmaceutical Manufacturing
・
5,001-10,000 employees
・
Paris, France
Ipsen is a global biopharmaceutical company focused on developing and delivering transformative medicines in oncology, rare disease, and neuroscience to patients across 88 countries.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@ipsen.com
Company Overview
Industry
Pharmaceutical Manufacturing
Founded
1929
Headquarters
Paris, France
Revenue
2.5B-$5B
FUNDING Stage
Public
Website
Key Executives
David Loew (Chief Executive Officer), Aymeric Le Chatelier (Executive Vice President, Chief Financial Officer), Etienne Delille (SVP, Chief Digital Information Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Ipsen?
Ipsen uses the first.last format, so Jane Smith would be jane.smith@ipsen.com.
What are Ipsen's three core therapeutic areas?
Ipsen focuses on oncology, rare disease, and neuroscience. The company's oncology portfolio alone covers therapies for nine forms of cancer, including renal cell carcinoma, hepatocellular carcinoma, and pancreatic cancer, building on more than 35 years of oncology experience.
How does Ipsen's Dysport product fit into its neuroscience strategy?
Dysport (abobotulinumtoxinA) is Ipsen's flagship neuroscience product, approved for spasticity and cervical dystonia. In 2026, new clinical data from the DIRECTION trial showed Dysport achieved longer-lasting symptom control compared to Botox in adults with upper limb spasticity.
Where are Ipsen's global R&D hubs located?
Ipsen operates four global R&D hubs, with key sites in Cambridge, Massachusetts, and London, UK, in addition to its Paris, France headquarters. Cambridge serves as the North American hub, positioned in the Kendall Square biotech cluster.
Who leads Ipsen and how many people does the company employ?
David Loew serves as Chief Executive Officer of Ipsen. The company employs approximately 6,614 people globally and operates in markets across more than 40 countries, with products registered in 88 countries.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating